Sector revisions Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 2026-09-18			5-day change	1st Jan Change
229.13 ^CHF	-1.98%		+0.52%	-

Sep. 17	Charles River Laboratories International Introduces Rapid Cell Banking Programs with Next-Generation Sequencing Characterization	CI
Sep. 17	Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
LONZA GROUP AG		23
IQVIA HOLDINGS INC.		18
REVOLUTION MEDICINES, INC.		20
BEONE MEDICINES AG		28
CELLTRION, INC.		22
MEDPACE HOLDINGS, INC.		12
ASCENDIS PHARMA A/S	-	20
EUROFINS SCIENTIFIC SE		14
TEMPUS AI, INC.		17
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
BIO-TECHNE CORPORATION		11
PHARMARON BEIJING CO., LTD.		11
GENSCRIPT BIOTECH CORPORATION		7
KYMERA THERAPEUTICS, INC.		22
ABIVAX		7
PROTAGONIST THERAPEUTICS, INC.		13
QIAGEN N.V.		15
PRAXIS PRECISION MEDICINES, INC.		19
Average		16
Weighted average by Cap.		19